DNA Synthesizer Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


The global DNA Synthesizer Market is estimated to be valued at US$ 4.3 Bn in 2023 and is expected to exhibit a CAGR of 20. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. 

Market Overview:

The DNA synthesizer market is highly concentrated with few major players accounting for a significant share. A DNA synthesizer is an automated machine used to synthesize short or long strands of DNA in the laboratory. It works on the basis of solid-phase synthesis techniques and phosphoramidite chemistry. DNA synthesizers offer advantages such as high synthesis quality, scalability, and reproducibility. With increasing application of DNA synthesizers in next-generation DNA sequencing, molecular diagnostics, and synthetic biology, the demand for DNA synthesizers is expected to rise substantially over the forecast period.

Read More @ https://www.coherentmarketinsights.com/market-insight/dna-synthesizer-market-5913

Market key trends:

Next-generation DNA sequencing (NGS) is one of the fastest growing application areas of DNA synthesizers that is fueling market growth. NGS requires generating a large number of DNA templates for library preparation, which is now possible with automated DNA synthesizers with high production capacity. Furthermore, continual technological improvements such as incorporation of microfluidics, revolutionary chemistries, and customizability of DNA sequences are supporting large-scale DNA synthesis for NGS. This is increasing adoption of DNA synthesizers among sequencing laboratories.

Segment Analysis

The global DNA synthesizer market is segmented into gene synthesis, oligonucleotide synthesis, and scientific R&D based on application. Among these, the oligonucleotide synthesis segment is dominating the market and accounted for more than 50% share in 2022. This is due to the wide applications of oligonucleotides in research, diagnostics, and therapeutics. Oligonucleotides are short synthetic strands of polynucleotides widely used in diagnostic applications such as DNA sequencing and genetic testing.

Key Takeaways

The global DNA synthesizer market is expected to witness high growth, exhibiting CAGR of 20% over the forecast period, due to increasing adoption of DNA synthesis tools in advanced gene synthesis technologies and genomics research.

Regional analysis

North America is currently the largest and fastest growing regional market for DNA synthesizers. The region accounted for over 35% share of the global market in 2022 due to advancing genomics research and increasing adoption of DNA synthesis technologies in academic research. Asia Pacific is also expected to grow at a significant CAGR over the next few years.

Key players

Key players operating in the DNA Synthesizer market are Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation, GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, New England Biolabs, Nippon Genetics, LGC Biosearch Technologies, DNA Script, Ribbon Biolabs GmbH, and Camena Bioscience.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

The Where and the How: Unraveling Biology's Spatial Enigma with Omics

-
Image
In the fast-evolving landscape of biomedical research, a revolutionary technique has emerged that promises to unlock new dimensions of understanding within cellular landscapes – Spatial Omics. This cutting-edge approach combines the power of genomics, transcriptomics, proteomics, and more, with spatial information, creating a holistic view of biological systems. At its core, Spatial Omics involves mapping the molecular composition of tissues with spatial context. Traditional omics techniques provide valuable insights into the molecules present in a sample, but they lack the crucial information about where these molecules are located within the tissue. Spatial Omics bridges this gap by preserving the spatial architecture, offering unprecedented insights into cellular interactions, organization, and function. Read More @   https://www.digitaljournal.com/pr/news/coherent-market-insights/spatial-omics-market-revenue-growth-rate-customer-needs-trend-manufacturers-and-forecast-to-2030-10...
Read more

Nanorobotics: Unlocking New Possibilities in Targeted Drug Delivery

-
Image
The nanorobotics industry involves engineering devices at the scale of nanometers to micrometers in order to perform tasks such as assembly and manipulation at molecular levels. Nanorobotic technologies have potential applications across various domains including biomedical sciences, agriculture, environmental remediation, material synthesis, and more. By enabling miniaturization, nanorobotic tools are able to precisely target and interact with cells and molecules within the human body, providing new methods for disease diagnosis and treatment.  The global nanorobotics market is estimated to be valued at USD 989.7 million in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period from 2023 to 2030. Key applications of nanorobots include targeted drug delivery, biological sensors, tissue engineering, molecular surgery, and biomedical research. For instance, nanorobots injected intravenously could be programmed to travel through blood vessels and locate microscopic tu...
Read more